Kentucky E-cigarette Lawsuit Seeks to Overturn State Ban

Regulations by 2FIRSTS.ai
Apr.25.2024
Kentucky E-cigarette Lawsuit Seeks to Overturn State Ban
Kentucky e-cigarette shops, retailers, and cannabis association sue to overturn state law restricting product sales beyond FDA-approved items.

According to a report by Lexingtonky on April 24th, four e-cigarette shops in Kentucky, the Kentucky Association of E-Cigarette Retailers, and the Kentucky Cannabis Association have filed a lawsuit in Franklin Circuit Court, seeking to overturn a state law that prohibits the sale of products other than those approved by the FDA.

 

Greg Troutman, a lawyer for the Kentucky Smoke-Free Association, said, "We hope to have a resolution before the law takes effect on January 1, 2023."

 

The lawsuit was filed last Friday (the 19th), with e-cigarette retailers arguing that the definition of "e-cigarette products" and "other substances" in House Bill 11 conflates e-cigarettes, cannabis e-cigarettes, and cannabis products, making it overly broad and arbitrary, failing to meet the requirements of the state constitution. Troutman also argues that it requires retailers to comply with regulatory procedures that do not exist for cannabis and other non-nicotine products, thus violating due process. The lawsuit states that once the law goes into effect, retailers will be penalized for selling cannabis derivatives.

 

Supporters of HB 11 tout the bill as a way to curb underage e-cigarette use by limiting the sale of "authorized products" or those products that are certified under a "safety harbor" with the U.S. Food and Drug Administration (FDA). The bill has received support from Altira, with records submitted to the Legislative Ethics Committee showing that Altira has spent over $500,000 on lobbying efforts since January 2022.

 

In this lawsuit, it is claimed that the new law requires the FDA to approve products that cannot obtain FDA approval, as the FDA does not have regulatory procedures in place for them, such as products containing Amanita muscaria and marijuana derivatives. According to the lawsuit, a law passed by the legislature last year will also apply to marijuana e-cigarette products set to be launched in Kentucky in 2025.

 

The lawsuit also alleges that the new law violates a provision in the state constitution that limits laws to a single subject. The lawsuit argues that the title of HB 11 is "An Act relating to products containing nicotine," but it applies to non-nicotine e-cigarette products, such as marijuana-derived products.

 

The defendants are Allyson Taylor, an official with the Kentucky Department of Alcohol Beverage Control, and Michael Adams, the Secretary of State.

 

In the final days of the conference, lawmakers merged House Bill 11 and Senate Bill 344, the latter establishing an e-cigarette registry. Governor Andy Beshear signed the merged bill on April 5th.

 

E-cigarette vendors say that this law could create a monopoly for large retailers and harm small businesses.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
Portugal and Other Countries Submit Objections in Brussels Over UK Smoke-Free Generation Bill
Portugal and Other Countries Submit Objections in Brussels Over UK Smoke-Free Generation Bill
Portugal is among the countries opposing the UK Tobacco and Vapes Bill, which would ban tobacco sales to people born on or after Jan. 1, 2009. According to the report, Portugal, Croatia, the Czech Republic, Greece, Italy, Slovakia and Romania have submitted reasoned opinions and formal observations to Brussels, arguing that the bill breaches post-Brexit arrangements including the Windsor Framework.
Apr.24 by 2FIRSTS.ai
Thailand’s Bangkok Port Customs Reports E-Cigarette and Nitrous Oxide Seizure Worth More Than THB 27 Million
Thailand’s Bangkok Port Customs Reports E-Cigarette and Nitrous Oxide Seizure Worth More Than THB 27 Million
Bangkok Port Customs on April 28 announced the seizure of 52,000 complete e-cigarettes, 100 gallons of e-liquid and 126,226 canisters of nitrous oxide, with total economic damage exceeding THB 27 million, or about USD 831,178 based on an April 28 USD/THB rate of 32.484. The e-cigarette and e-liquid shipment was valued at THB 5.56 million, or about USD 171,161, while the nitrous oxide shipment was valued at THB 21.27 million, or about USD 654,784.
Apr.29 by 2FIRSTS.ai
Spanish parties PP and PSOE reach agreement on sales restrictions for e-cigarettes and nicotine pouches
Spanish parties PP and PSOE reach agreement on sales restrictions for e-cigarettes and nicotine pouches
Spain’s Popular Party and Socialist Party reached an agreement in the Joint Congress-Senate Commission for the Study of Addiction Problems and approved a non-binding motion calling for the sale of e-cigarettes, nicotine pouches and related products to be limited to authorized and controlled channels, such as tobacco shops and specialized stores, while excluding internet sales and general retail outlets.
Apr.27 by 2FIRSTS.ai
Russian Public Group Seeks Website Restrictions on Remote Vape and Nicotine Sales
Russian Public Group Seeks Website Restrictions on Remote Vape and Nicotine Sales
Russian public movement “Healthy Fatherland,” has proposed blocking access in Russia to online resources that sell vapes and nicotine-containing products remotely.
Apr.15 by 2FIRSTS.ai
PMI U.S. White Paper Calls for Greater Access to FDA-Authorized Smoke-Free Alternatives and Risk-Based Taxation
PMI U.S. White Paper Calls for Greater Access to FDA-Authorized Smoke-Free Alternatives and Risk-Based Taxation
PMI’s U.S. business released a white paper and cited a national online survey showing that 79.00% of Americans surveyed believe more should be done to reduce smoking-related harm. The paper calls on policymakers, public health authorities, and medical professionals to place cigarette smoking back at the center of public health priorities, and recommends broader access to FDA-authorized smoke-free alternatives, clearer nicotine risk communication, and risk-based taxation.
Apr.15 by 2FIRSTS.ai